These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38100939)

  • 1. Risk factors of massive blood transfusion (MTP) in cesarean hysterectomy for placenta accreta spectrum.
    Munoz JL; Ramsey PS; Greebon LJ; Salazar E; McCann GA; Byrne JJ
    Eur J Obstet Gynecol Reprod Biol; 2024 Feb; 293():32-35. PubMed ID: 38100939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum.
    Zuckerwise LC; Craig AM; Newton JM; Zhao S; Bennett KA; Crispens MA
    Am J Obstet Gynecol; 2020 Feb; 222(2):179.e1-179.e9. PubMed ID: 31469990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Antenatal Vaginal Bleeding and Adverse Perinatal Outcomes in Placenta Accreta Spectrum.
    Mulhall JC; Ireland KE; Byrne JJ; Ramsey PS; McCann GA; Munoz JL
    Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674323
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk factors for intensive care unit admission after cesarean hysterectomy for placenta accreta spectrum.
    Munoz JL; Cheng C; McCann GA; Ramsey P; Byrne JJ
    Int J Gynaecol Obstet; 2024 Nov; 167(2):656-662. PubMed ID: 38757543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the gynecologic oncologist in management of cesarean hysterectomy for Placenta Accreta Spectrum (PAS).
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Gynecol Oncol; 2022 Sep; 166(3):460-464. PubMed ID: 35781164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reloadable Stapler Use during Peripartum Hysterectomy for Placenta Accreta Spectrum: A Novel Surgical Technique and Case Series.
    Smith CG; Cottrill HM; Barton JR
    Am J Perinatol; 2022 Feb; 39(3):265-271. PubMed ID: 32819018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placenta Accreta Spectrum Treatment With Intraoperative Multivessel Embolization: the PASTIME protocol.
    Melber DJ; Berman ZT; Jacobs MB; Picel AC; Conturie CL; Zhang-Rutledge K; Binder PS; Eskander RN; Roberts AC; McHale MT; Ramos GA; Ballas J; Kelly TF
    Am J Obstet Gynecol; 2021 Oct; 225(4):442.e1-442.e10. PubMed ID: 34245679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraxial to general anesthesia conversion has equitable intraoperative and improved post-operative outcomes compared to general anesthesia in cesarean hysterectomy for placenta accreta spectrum (PAS).
    Munoz JL; Pfeiffer AF; Curbelo J; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8640-8644. PubMed ID: 34657560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal outcomes of conservative management and cesarean hysterectomy for placenta accreta spectrum disorders: a systematic review and meta-analysis.
    Pan S; Han M; Zhai T; Han Y; Lu Y; Huang S; Zuo Q; Jiang Z; Ge Z
    BMC Pregnancy Childbirth; 2024 Jul; 24(1):463. PubMed ID: 38969992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal-occult placenta accreta: a clandestine source of maternal morbidity.
    Larish A; Horst K; Brunton J; Schenone M; Branda M; Mehta R; Packard A; VanBuren W; Norgan A; Shahi M; Missert A; Pompeian R; Greenwood J; Theiler R
    Am J Obstet Gynecol MFM; 2023 Jun; 5(6):100924. PubMed ID: 36934974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies.
    Munoz JL; Kimura AM; Julia J; Tunnell C; Hernandez B; Curbelo J; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10692-10697. PubMed ID: 36521848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team.
    Erfani H; Fox KA; Clark SL; Rac M; Rocky Hui SK; Rezaei A; Aalipour S; Shamshirsaz AA; Nassr AA; Salmanian B; Stewart KA; Kravitz ES; Eppes C; Coburn M; Espinoza J; Teruya J; Belfort MA; Shamshirsaz AA
    Am J Obstet Gynecol; 2019 Oct; 221(4):337.e1-337.e5. PubMed ID: 31173748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placenta accreta spectrum: We can do better.
    Silveira C; Kirby A; Melov SJ; Nayyar R
    Aust N Z J Obstet Gynaecol; 2022 Jun; 62(3):376-382. PubMed ID: 34984671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation and outcomes of a uterine artery embolization and tranexamic acid protocol for placenta accreta spectrum.
    Munoz JL; Blankenship LM; Ramsey PS; McCann GA
    Am J Obstet Gynecol; 2023 Jul; 229(1):61.e1-61.e7. PubMed ID: 36965865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of a False-Positive Antenatal Diagnosis of Placenta Accreta Spectrum.
    Salmanian B; Shamshirsaz AA; Fox KA; Asl NM; Erfani H; Detlefs SE; Coburn M; Espinoza J; Nassr A; Belfort MA; Clark SL; Shamshirsaz AA
    Am J Perinatol; 2024 Jan; 41(2):187-192. PubMed ID: 34666389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of pregnancies complicated by placenta accreta spectrum utilizing a multidisciplinary care team in a rural state.
    Sandlin AT; Magann EF; Whittington JR; Schneider AM; Ramseyer AM; Hughes DS; Ounpraseuth ST
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5964-5969. PubMed ID: 33769169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole blood transfusion reduces overall component transfusion in cases of placenta accreta spectrum: a pilot program.
    Munoz JL; Kimura AM; Xenakis E; Jenkins DH; Braverman MA; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6455-6460. PubMed ID: 33902384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.
    Lucidi A; Jauniaux E; Hussein AM; Coutinho CM; Tinari S; Khalil A; Shamshirsaz A; Palacios-Jaraquemada JM; D'Antonio F
    Ultrasound Obstet Gynecol; 2023 Nov; 62(5):633-643. PubMed ID: 37401769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood loss and use of blood products in cases of cesarean hysterectomy for placenta accrete].
    Solórzano-Vázquez JF; Hernández-Higareda S; Segura-Zavala JM; OsegueraTorres LF; De la Rosa-Hernández SS
    Ginecol Obstet Mex; 2016 Aug; 84(8):491-7. PubMed ID: 29424510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An obstetric-specific surgical Apgar score predicts maternal morbidity from cesarean hysterectomy for placenta accreta spectrum.
    Munoz JL; Curbelo J; Ramsey PS
    Int J Gynaecol Obstet; 2024 Mar; 164(3):912-917. PubMed ID: 37668180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.